N-glycan based biomarker distinguishing non-alcoholic steatohepatitis from steatosis independently of fibrosis

Digestive and Liver Disease

Volumn 44, Issue 4, 2012, Pages 315-322

  Blomme, Bram ^a   Francque, Sven ^b   Trépo, Eric ^c   Libbrecht, Louis ^a   Vanderschaeghe, Dieter ^d   Verrijken, An ^b   Pattyn, Piet ^a   Van Nieuwenhove, Yves ^a   Van De Putte, Dirk ^a   Geerts, Anja ^a   Colle, Isabelle ^a   Delanghe, Joris ^a   Moreno, Christophe ^c   Van Gaal, Luc ^b   Callewaert, Nico ^d   Van Vlierberghe, Hans ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c ERASME HOSPITAL   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

Capillary; Electrophoresis; Glycomics; Immunoglobulin G; Inflammation

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKERATIN 18; FERRITIN; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMA PROTEIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CAPILLARY ELECTROPHORESIS; DNA SEQUENCE; FATTY LIVER; FEMALE; GLYCOSYLATION; HEPATITIS; HISTOPATHOLOGY; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PILOT STUDY; PRIORITY JOURNAL; VALIDATION STUDY; WAIST HIP RATIO;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; ELECTROPHORESIS, CAPILLARY; FATTY LIVER; FEMALE; GLYCOMICS; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; RETROSPECTIVE STUDIES;

EID: 84857643827     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.10.015     Document Type: Article

References (36)

1. Catenacci V.A., Hill J.O., Wyatt H.R. The obesity epidemic. Clin Chest Med 2009, 30:415-444.
2. Tarantino G., Saldalamacchia G., Conca P., et al. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol 2007, 22:293-303.
3. Browning J.D. New imaging techniques for non-alcoholic steatohepatitis. Clin Liver Dis 2009, 13:607-619.
4. Promrat K., Kleiner D.E., Niemeier H.M., et al. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010, 51:121-129.
5. Hossain N., Afendy A., Stepanova M., et al. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009, 7:1224-1229.
6. Chitturi S., Abeygunasekera S., Farrell G.C., et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002, 35:373-379.
7. Tsochatzis E.A., Papatheodoridis G.V., Archimandritis A.J. Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy. Mediators Inflamm 2009, 2009:831670.
8. Dixon J.B., Bhathal P.S., O'Brien P.E. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg 2006, 16:1278-1286.
9. Brunt E.M., Neuschwander-Tetri B.A., Oliver D., et al. Nonalcoholic steatohepatitis: histologic features and clinical correlations with 30 blinded biopsy specimens. Hum Pathol 2004, 35:1070-1082.
10. Clark J.M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006, 40(Suppl. 1):S5-S10.
11. Kashyap S.R., Diab D.L., Baker A.R., et al. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort. Obesity (Silver Spring) 2009, 17:1696-1701.
12. Liew P.L., Lee W.J., Lee Y.C., et al. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Obes Surg 2006, 16:1584-1593.
13. Younossi Z.M., Jarrar M., Nugent C., et al. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes Surg 2008, 18:1430-1437.
14. Bantel H., Bahr M.J., Schulze-Osthoff K. An apoptosis biomarker for prediction of nonalcoholic steatohepatitis. Hepatology 2009, 50:991.
15. Tarantino G., Conca P., Coppola R., et al. Serum concentrations of the tissue specific antigen in patients suffering from non-alcoholic steatohepatitis. Eur J Clin Invest 2007, 37:48-53.
16. Callewaert N., Van Vlierberghe H., Van Hecke A., et al. Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics. Nat Med 2004, 10:429-434.
17. Liu X.E., Desmyter L., Gao C.F., et al. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus. Hepatology 2007, 46:1426-1435.
18. Vanderschaeghe D., Laroy W., Sablon E., et al. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Mol Cell Proteomics 2009, 8:986-994.
19. Klein A., Carre Y., Louvet A., et al. Immunoglobulins are the major glycoproteins involved in the modifications of the total serum N-glycome in cirrhotic patients. Proteomics Clin Appl 2010, 4:379-393.
20. Ma K.L., Ruan X.Z., Powis S.H., et al. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice. Hepatology 2008, 48:770-781.
21. Tarantino G., Conca P., Pasanisi F., et al. Could inflammatory markers help diagnose nonalcoholic steatohepatitis?. Eur J Gastroenterol Hepatol 2009, 21:504-511.
22. Kleiner D., Brunt E., Van Natta M., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
23. Debruyne E., Vanderschaeghe D., Van Vlierberghe H., et al. Diagnostic value of the hemopexin N-glycan in hepatocellular carcinoma patients. Clin Chem 2010, 56:823-831.
24. Laroy W., Contreras R., Callewaert N. Glycome mapping on DNA sequencing equipment. Nat Protoc 2006, 1:397-405.
25. Mehta S.H., Lau B., Afdhal N.H., et al. Exceeding the limits of histology markers. J Hepatol 2009, 50:36-41.
26. Feldstein A.E., Wieckowska A., Lopez A.R., et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009, 50:1072-1078.
27. André P., Balkau B., Vol S., et al. Gamma-glutamyltransferase activity and development of the metabolic syndrome (International Diabetes Federation Definition) in middle-aged men and women. Diabetes Care 2007, 30:2355-2361.
28. Sorrentino P., Tarantino G., Conca P., et al. Silent non-alcoholic fatty liver disease-a clinical-histological study. J Hepatol 2004, 41:751-757.
29. Fracanzani A., Valenti L., Bugianesi E., et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin and diabetes. Hepatology 2008, 48:792-798.
30. Van Beneden K., Coppieters K., Laroy W., et al. Reversible changes in serum immunoglobulin galactosylation during the immune response and treatment of inflammatory autoimmune arthritis. Ann Rheum Dis 2009, 68:1360-1365.
31. Hotamisligil G., Spiegelman B.M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994, 43:1271-1278.
32. Shoelson S., Herrero L., Naaz A. Obesity, inflammation and insulin resistance. Gastroenterology 2007, 132:2169-2180.
33. Tarantino G., Conca P., Riccio A., et al. Enhanced serum concentrations of transforming growth factor-beta I in simple fatty liver: is it benign?. J Trans Med 2008, 6:72-79.
34. Ahishali E., Demir K., Ahishali B., et al. Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis?. J Gastroenterol Hepatol 2010, 25:619-626.
35. Chen C., Schmilovitz-Weiss H., Liu X.E., et al. Serum protein N-glycans profiling for the discovery of potential biomarkers for nonalcoholic steatohepatitis. J Proteome Res 2009, 8:463-470.
36. Vanderschaeghe D., Szekrényes A., Wenz C., et al. High-throughput profiling of the serum N-glycome on capillary electrophoresis microfluids systems: toward clinical implementation of GlycoHepatoTest. Anal Chem 2010, 82:7408-7415.